Let's Win! Pancreatic Cancer Foundation

Let’s Win! Pancreatic Cancer is an unprecedented platform that enables doctors, scientists, and patients to share fast-breaking information on potentially life-saving pancreatic cancer treatments and clinical trials. Our goal is to inform, enable, and educate patients and caregivers, providing easy-to-understand, actionable information. In this way we can help people find the best treatment options available.

Through Let’s Win!, patients and their families can share information about their diagnoses and the novel treatments they have undertaken beyond traditional protocols, and they can learn from experts how to better manage and improve their quality of life.

Latest from Let's Win! Pancreatic Cancer Foundation

Identifying Biomarkers for Early Detection of Pancreatic Cancer

November 04, 2021

Article

A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.

New-Onset Diabetes Plus Unintentional Weight Loss Emerging as an Important Clue In Earlier Detection

October 28, 2021

Article

Dr. Brian Wolpin outlines the connection between unintentional weight loss, new-onset diabetes and pancreatic cancer.

Will New-Onset Diabetes Provide a Way to Detect Pancreatic Cancer Earlier?

October 21, 2021

Article

Dr. Anirban Maitra, Dr. Suresh Chari, and others are looking at the relationship between new-onset diabetes and pancreatic cancer.

Lack of Diversity in Pancreatic Cancer Trials

October 14, 2021

Article

Dr. Kelly Herremans and Dr. Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.

Sharing My Knowledge With Others

October 07, 2021

Article

David Dessert knew that his father carried the BRCA2 mutation, so he told his doctor, who developed a treatment plan accordingly.

My Strength Comes From My Mother

September 30, 2021

Article

Kim Vernick credits her mother with passing down her positivity and strength, qualities that have helped her get through pancreatic cancer, a recurrence and esophageal cancer.